Takayasu, K., K. Muguruma, and H. Kinoshita. “Durable Complete Response to Combination Nivolumab and Ipilimumab in Metastatic Renal Cell Carcinoma”. Trends in Immunotherapy, vol. 6, no. 1, Jan. 2022, doi:10.24294/ti.v6.i1.1387.